| Mobile Web

LG CNS completes AI drug discovery platform for Dong-A Socio Group

LG CNS said on Tuesday it has completed an AI drug discovery platform for Dong-A Socio Group, built with the group’s IT affiliate DAI. The platform integrates and standardises drug research data and supports key processes from candidate discovery to design and validation using AI. It analyses gene and tissue location data to help identify targets, uses generative AI to design compound structures, and simulates binding and stability in validation.